Dr. Ilisa Bernstein, Deputy Director (CDER) at FDA will be attending and speaking at PharmaLink 2016. Her session, “Office of Compliance Key Initiatives” will kick-off the Conference. The top strategic priorities of the CDER Office of Compliance will be shared so attendees can understand how these key initiatives involve and impact industry. This session will address topics, such as domestic and foreign enforcement trends, surveillance activities and drug shortages.
To view all of the Speakers and Moderators for the 2016 please click here.